As a result, the identification of five prospective gene biomarkers that are differently expressed in AD, such as SELE, TGFβ1, MYH11, ITGB1, and CXCR4, offers possibilities for clinically diagnostic biomarkers that can identify AD patients. Here, SELE is linked to Alzheimer disease.